[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-001", "question": "A 74-year-old man presents with heart failure with preserved ejection fraction (HFpEF) and bilateral carpal tunnel syndrome. Echocardiography reveals a granular 'sparkling' appearance of the myocardium and increased wall thickness. A technetium-99m pyrophosphate (PYP) scan shows Grade 3 cardiac uptake (uptake > rib uptake). Serum immunofixation reveals a small IgG lambda monoclonal protein, and serum free light chain ratio is 1.8. Which of the following is the most appropriate next step in management to confirm the diagnosis?", "options": ["Initiate tafamidis therapy", "Perform TTR genetic testing", "Endomyocardial biopsy", "Abdominal fat pad aspiration", "Initiate bortezomib, cyclophosphamide, and dexamethasone"], "answer": "C", "answer_index": 2, "explanation": "While Grade 2/3 PYP uptake is highly specific for ATTR cardiac amyloidosis, this specificity drops significantly in the presence of a monoclonal gammopathy (MGUS). AL amyloidosis can occasionally show uptake on PYP scans. Therefore, in a patient with a positive PYP scan AND a monoclonal protein, a tissue biopsy (endomyocardial is gold standard if non-cardiac biopsy is negative or to avoid sampling error) is mandatory to distinguish ATTR from AL amyloidosis before starting treatment.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item accurately tests the 'non-biopsy diagnosis' criteria for ATTR cardiac amyloidosis. According to multi-society guidelines (ASNC/AHA/ASE), a Grade 2/3 PYP scan is diagnostic for ATTR only in the absence of a monoclonal protein. This patient has a positive PYP scan and a monoclonal protein (IgG lambda, abnormal ratio), creating a diagnostic dilemma (ATTR with incidental MGUS vs. AL amyloidosis with PYP uptake). Therefore, tissue confirmation with amyloid typing is mandatory before initiating therapy. While abdominal fat pad aspiration (Option D) is a possible initial tissue test, its sensitivity for ATTR (especially wild-type) is low; a negative result would require proceeding to endomyocardial biopsy (Option C) anyway. Given the high pre-test probability of ATTR (Grade 3 PYP), Endomyocardial Biopsy is the most direct and definitive step to confirm the diagnosis and distinguish ATTR from AL. The logic is sound, and the distractors are appropriate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item accurately tests the 'non-biopsy diagnosis' criteria for ATTR cardiac amyloidosis. According to multi-society guidelines (ASNC/AHA/ASE), a Grade 2/3 PYP scan is diagnostic for ATTR only in the absence of a monoclonal protein. This patient has a positive PYP scan and a monoclonal protein (IgG lambda, abnormal ratio), creating a diagnostic dilemma (ATTR with incidental MGUS vs. AL amyloidosis with PYP uptake). Therefore, tissue confirmation with amyloid typing is mandatory before initiating therapy. While abdominal fat pad aspiration (Option D) is a possible initial tissue test, its sensitivity for ATTR (especially wild-type) is low; a negative result would require proceeding to endomyocardial biopsy (Option C) anyway. Given the high pre-test probability of ATTR (Grade 3 PYP), Endomyocardial Biopsy is the most direct and definitive step to confirm the diagnosis and distinguish ATTR from AL. The logic is sound, and the distractors are appropriate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-002", "question": "A 24-year-old male presents with recurrent fevers, livedo racemosa, and acute left hemiparesis. MRI shows a lacunar infarct in the internal capsule. Angiography reveals a 'beads-on-a-string' appearance in the mesenteric and renal arteries. Laboratory evaluation shows low serum IgM and IgG levels. Genetic testing confirms a biallelic loss-of-function mutation in ADA2. Which of the following is the most appropriate maintenance therapy?", "options": ["Cyclophosphamide", "Rituximab", "Etanercept", "Prednisone monotherapy", "Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "The patient has Deficiency of Adenosine Deaminase 2 (DADA2), which mimics Polyarteritis Nodosa (PAN) but is distinct due to its association with early-onset strokes and hypogammaglobulinemia. Unlike classic PAN, which is treated with cyclophosphamide, DADA2 is driven by TNF-alpha dysregulation. TNF inhibitors (like etanercept) are the treatment of choice and are highly effective in preventing recurrent strokes, whereas cyclophosphamide is often ineffective.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette presents a classic case of Deficiency of Adenosine Deaminase 2 (DADA2), characterized by early-onset stroke, livedo racemosa, PAN-like vasculopathy ('beads-on-a-string'), hypogammaglobulinemia, and confirmatory genetics. The question asks for the most appropriate maintenance therapy. Current medical consensus and literature establish TNF inhibitors (such as Etanercept) as the treatment of choice for DADA2, specifically to prevent recurrent strokes and control vasculitis. While Cyclophosphamide (Option A) is the standard of care for classic Polyarteritis Nodosa (PAN), it is significantly less effective in DADA2 and does not reliably prevent strokes. Rituximab (Option B) is generally unsuitable due to the patient's existing hypogammaglobulinemia. Prednisone (Option D) is not appropriate for long-term maintenance monotherapy. Therefore, the item is medically accurate, logically sound, and relies on a specific, well-defined distinction between DADA2 and classic PAN.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette presents a classic case of Deficiency of Adenosine Deaminase 2 (DADA2), characterized by early-onset stroke, livedo racemosa, PAN-like vasculopathy ('beads-on-a-string'), hypogammaglobulinemia, and confirmatory genetics. The question asks for the most appropriate maintenance therapy. Current medical consensus and literature establish TNF inhibitors (such as Etanercept) as the treatment of choice for DADA2, specifically to prevent recurrent strokes and control vasculitis. While Cyclophosphamide (Option A) is the standard of care for classic Polyarteritis Nodosa (PAN), it is significantly less effective in DADA2 and does not reliably prevent strokes. Rituximab (Option B) is generally unsuitable due to the patient's existing hypogammaglobulinemia. Prednisone (Option D) is not appropriate for long-term maintenance monotherapy. Therefore, the item is medically accurate, logically sound, and relies on a specific, well-defined distinction between DADA2 and classic PAN.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-003", "question": "A 64-year-old male presents with a 1-year history of progressive gait instability, dysarthria, and dysphagia. His wife reports he has severe insomnia, stridor during sleep, and acts out his dreams. Polysomnography confirms obstructive sleep apnea and complex behaviors during both REM and NREM sleep. MRI brain is unremarkable. Which of the following antibodies is most likely to be positive?", "options": ["Anti-Hu", "Anti-Ma2", "Anti-LGI1", "Anti-IgLON5", "Anti-DPPX"], "answer": "D", "answer_index": 3, "explanation": "Anti-IgLON5 disease is a distinct tauopathy characterized by a unique sleep disorder (parasomnias in both REM and NREM sleep, stridor, OSA) combined with bulbar dysfunction and gait instability. While Anti-Ma2 is associated with brainstem/diencephalic involvement and sleepiness, the specific combination of stridor, NREM parasomnias, and bulbar palsy is pathognomonic for Anti-IgLON5.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes the classic clinical phenotype of anti-IgLON5 disease. Key discriminating features include the combination of bulbar dysfunction (dysarthria, dysphagia), gait instability, and a distinctive sleep disorder characterized by parasomnias occurring in both REM and NREM sleep, along with sleep-related stridor and obstructive sleep apnea. This specific constellation of symptoms is highly specific for anti-IgLON5 disease (Option D). Anti-Hu (Option A) is typically associated with paraneoplastic sensory neuronopathy or encephalomyelitis (often with SCLC) but does not present with this specific sleep phenotype. Anti-Ma2 (Option B) is associated with diencephalic/brainstem encephalitis and narcolepsy-like sleepiness/cataplexy, rather than the complex REM/NREM parasomnias and stridor described. Anti-LGI1 (Option C) presents with faciobrachial dystonic seizures and limbic encephalitis. Anti-DPPX (Option E) is associated with a prodrome of diarrhea and CNS hyperexcitability (myoclonus, tremor). The item is medically accurate, logically sound, and points to a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes the classic clinical phenotype of anti-IgLON5 disease. Key discriminating features include the combination of bulbar dysfunction (dysarthria, dysphagia), gait instability, and a distinctive sleep disorder characterized by parasomnias occurring in both REM and NREM sleep, along with sleep-related stridor and obstructive sleep apnea. This specific constellation of symptoms is highly specific for anti-IgLON5 disease (Option D). Anti-Hu (Option A) is typically associated with paraneoplastic sensory neuronopathy or encephalomyelitis (often with SCLC) but does not present with this specific sleep phenotype. Anti-Ma2 (Option B) is associated with diencephalic/brainstem encephalitis and narcolepsy-like sleepiness/cataplexy, rather than the complex REM/NREM parasomnias and stridor described. Anti-LGI1 (Option C) presents with faciobrachial dystonic seizures and limbic encephalitis. Anti-DPPX (Option E) is associated with a prodrome of diarrhea and CNS hyperexcitability (myoclonus, tremor). The item is medically accurate, logically sound, and points to a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-004", "question": "A 68-year-old male presents with fever of unknown origin, 15 kg weight loss, and fatigue 4 years after undergoing aortic valve replacement. Labs reveal pancytopenia and elevated liver enzymes. TTE and TEE show no vegetations. PET-CT demonstrates hypermetabolic activity in the spleen and bone marrow. Bone marrow biopsy reveals non-caseating granulomas. Standard blood cultures are negative. Which of the following is the most likely etiology?", "options": ["Sarcoidosis", "Culture-negative endocarditis (HACEK group)", "Mycobacterium chimaera", "Tropheryma whipplei", "Late-onset prosthetic valve thrombosis"], "answer": "C", "answer_index": 2, "explanation": "This is the classic presentation of disseminated *Mycobacterium chimaera* infection associated with contaminated heater-cooler units used during cardiopulmonary bypass. The incubation period can be several years. It presents with systemic symptoms, cytopenias, and granulomatous inflammation (often misdiagnosed as sarcoidosis). Diagnosis requires specific mycobacterial blood cultures or tissue PCR.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"This is a high-quality, valid board-style question. The vignette presents the classic triad for disseminated Mycobacterium chimaera infection: 1) history of cardiac surgery with cardiopulmonary bypass (exposure to contaminated heater-cooler units), 2) long latency period (4 years is typical), and 3) systemic granulomatous inflammation (pancytopenia, splenomegaly, non-caseating granulomas). While Sarcoidosis (Option A) is a differential diagnosis for non-caseating granulomas, the specific history of aortic valve replacement acts as the critical discriminating clue that points to M. chimaera. Standard blood cultures are typically negative, and echocardiography often fails to show vegetations in these cases, making Options B and E incorrect. Tropheryma whipplei (Option D) can cause culture-negative endocarditis but is less strongly associated with this specific constellation of post-surgical granulomatous marrow involvement. The item is medically accurate and logically sound, requiring the examinee to link the surgical history to the specific pathogen.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "This is a high-quality, valid board-style question. The vignette presents the classic triad for disseminated Mycobacterium chimaera infection: 1) history of cardiac surgery with cardiopulmonary bypass (exposure to contaminated heater-cooler units), 2) long latency period (4 years is typical), and 3) systemic granulomatous inflammation (pancytopenia, splenomegaly, non-caseating granulomas). While Sarcoidosis (Option A) is a differential diagnosis for non-caseating granulomas, the specific history of aortic valve replacement acts as the critical discriminating clue that points to M. chimaera. Standard blood cultures are typically negative, and echocardiography often fails to show vegetations in these cases, making Options B and E incorrect. Tropheryma whipplei (Option D) can cause culture-negative endocarditis but is less strongly associated with this specific constellation of post-surgical granulomatous marrow involvement. The item is medically accurate and logically sound, requiring the examinee to link the surgical history to the specific pathogen.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-005", "question": "A 31-year-old female presents with amenorrhea 4 months after a full-term delivery. Ultrasound reveals a 4 cm echogenic mass in the myometrium. Serum beta-hCG is 120 IU/L. Immunohistochemistry of a biopsy specimen shows diffuse positivity for human placental lactogen (hPL) and Ki-67 index of 15%. Staging workup is negative for metastasis. What is the treatment of choice?", "options": ["Methotrexate and Folinic Acid", "Actinomycin D", "EMA-CO regimen", "Hysterectomy", "Pembrolizumab"], "answer": "D", "answer_index": 3, "explanation": "The diagnosis is Placental Site Trophoblastic Tumor (PSTT), distinguished from choriocarcinoma by low beta-hCG, strong hPL positivity, and origin from intermediate trophoblasts. Unlike choriocarcinoma, PSTT is relatively resistant to chemotherapy. For localized (Stage I) disease, hysterectomy is the primary and definitive treatment. Chemotherapy is reserved for metastatic or high-risk disease.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette describes a classic presentation of Placental Site Trophoblastic Tumor (PSTT). Key diagnostic features include the antecedent pregnancy, the uterine mass, the relatively low beta-hCG level (120 IU/L) compared to tumor burden (unlike choriocarcinoma), and the specific immunohistochemical profile (diffuse hPL positivity, Ki-67 ~15%). Standard management for Stage I (localized) PSTT differs from other Gestational Trophoblastic Neoplasias (GTN) because PSTT is relatively chemo-resistant. Therefore, the first-line treatment for non-metastatic disease is hysterectomy (Option D). Chemotherapy (Options A, B, C) is generally reserved for metastatic or high-risk disease, and single-agent methotrexate/actinomycin D is typically ineffective. Pembrolizumab is a salvage option. The item is medically accurate, the distractors are appropriate for other GTN types, and the key is the unique best answer supported by major guidelines (FIGO/NCCN).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette describes a classic presentation of Placental Site Trophoblastic Tumor (PSTT). Key diagnostic features include the antecedent pregnancy, the uterine mass, the relatively low beta-hCG level (120 IU/L) compared to tumor burden (unlike choriocarcinoma), and the specific immunohistochemical profile (diffuse hPL positivity, Ki-67 ~15%). Standard management for Stage I (localized) PSTT differs from other Gestational Trophoblastic Neoplasias (GTN) because PSTT is relatively chemo-resistant. Therefore, the first-line treatment for non-metastatic disease is hysterectomy (Option D). Chemotherapy (Options A, B, C) is generally reserved for metastatic or high-risk disease, and single-agent methotrexate/actinomycin D is typically ineffective. Pembrolizumab is a salvage option. The item is medically accurate, the distractors are appropriate for other GTN types, and the key is the unique best answer supported by major guidelines (FIGO/NCCN).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-006", "question": "A 40-year-old male with a known diagnosis of Brugada syndrome presents to the ER in electrical storm, having received 4 appropriate ICD shocks for ventricular fibrillation in the past hour. He is currently conscious but anxious. Vital signs are BP 110/70, HR 90. Which pharmacologic agent is most appropriate to suppress the arrhythmia?", "options": ["Intravenous Amiodarone", "Intravenous Lidocaine", "Intravenous Isoproterenol", "Intravenous Procainamide", "Intravenous Metoprolol"], "answer": "C", "answer_index": 2, "explanation": "In Brugada syndrome electrical storm, the goal is to decrease the ST-segment elevation and dispersion. Isoproterenol (a beta-agonist) increases heart rate and calcium current, normalizing the ST segment and suppressing VF. Quinidine is the oral alternative. Amiodarone, beta-blockers, and sodium channel blockers (Procainamide, Lidocaine) are contraindicated or ineffective as they can unmask or exacerbate the Brugada pattern.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic scenario of electrical storm in a patient with Brugada syndrome. The pathophysiology of Brugada syndrome typically involves loss-of-function mutations in sodium channels, and arrhythmogenesis is often bradycardia-dependent or exacerbated by vagal tone. Current guidelines (e.g., HRS/EHRA/APHRS) recommend Isoproterenol infusion as the first-line acute pharmacologic therapy for electrical storm in Brugada syndrome. Isoproterenol increases heart rate and intracellular calcium, reducing the transmural voltage gradient and suppressing VF. The distractors are well-chosen as agents used for other types of VT but contraindicated or ineffective here: Procainamide (Class IA) and other sodium channel blockers unmask the Brugada pattern and are contraindicated. Beta-blockers (Metoprolol) can worsen the condition by slowing the heart rate. Amiodarone is generally ineffective and potentially harmful due to its sodium-channel blocking effects. Therefore, Option C is the unique, medically correct best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic scenario of electrical storm in a patient with Brugada syndrome. The pathophysiology of Brugada syndrome typically involves loss-of-function mutations in sodium channels, and arrhythmogenesis is often bradycardia-dependent or exacerbated by vagal tone. Current guidelines (e.g., HRS/EHRA/APHRS) recommend Isoproterenol infusion as the first-line acute pharmacologic therapy for electrical storm in Brugada syndrome. Isoproterenol increases heart rate and intracellular calcium, reducing the transmural voltage gradient and suppressing VF. The distractors are well-chosen as agents used for other types of VT but contraindicated or ineffective here: Procainamide (Class IA) and other sodium channel blockers unmask the Brugada pattern and are contraindicated. Beta-blockers (Metoprolol) can worsen the condition by slowing the heart rate. Amiodarone is generally ineffective and potentially harmful due to its sodium-channel blocking effects. Therefore, Option C is the unique, medically correct best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-007", "question": "A 32-year-old female presents with subacute confusion, bilateral hearing loss, and visual field deficits. MRI brain shows multiple T2 hyperintense lesions in the corpus callosum ('snowballs') and periventricular white matter. Fluorescein angiography reveals multiple branch retinal artery occlusions (BRAO). CSF shows mild pleocytosis and elevated protein but no oligoclonal bands. What is the most likely diagnosis?", "options": ["Multiple Sclerosis", "CADASIL", "Susac Syndrome", "Primary CNS Angiitis", "Mitochondrial Encephalomyopathy (MELAS)"], "answer": "C", "answer_index": 2, "explanation": "Susac Syndrome is a rare autoimmune endotheliopathy characterized by the clinical triad of encephalopathy, branch retinal artery occlusions (BRAO), and sensorineural hearing loss. The MRI finding of 'snowball' lesions in the corpus callosum is highly characteristic. It is often misdiagnosed as MS, but the presence of BRAO and callosal lesions (rather than callososeptal interface lesions) distinguishes it.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. The vignette presents a classic textbook description of Susac Syndrome, characterized by the clinical triad of encephalopathy (confusion), branch retinal artery occlusions (BRAO), and sensorineural hearing loss. The MRI finding of 'snowball' lesions in the corpus callosum is pathognomonic for this condition. The negative oligoclonal bands help distinguish it from Multiple Sclerosis (Option A), which is the primary differential but does not typically present with BRAO or this specific callosal lesion morphology. CADASIL (Option B) typically involves the anterior temporal lobes and lacks BRAO. Primary CNS Angiitis (Option D) and MELAS (Option E) do not fit the specific triad or the pathognomonic MRI findings. The item is medically accurate, logically sound, and the key is uniquely defensible based on the provided details.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. The vignette presents a classic textbook description of Susac Syndrome, characterized by the clinical triad of encephalopathy (confusion), branch retinal artery occlusions (BRAO), and sensorineural hearing loss. The MRI finding of 'snowball' lesions in the corpus callosum is pathognomonic for this condition. The negative oligoclonal bands help distinguish it from Multiple Sclerosis (Option A), which is the primary differential but does not typically present with BRAO or this specific callosal lesion morphology. CADASIL (Option B) typically involves the anterior temporal lobes and lacks BRAO. Primary CNS Angiitis (Option D) and MELAS (Option E) do not fit the specific triad or the pathognomonic MRI findings. The item is medically accurate, logically sound, and the key is uniquely defensible based on the provided details.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-008", "question": "A 29-year-old male who has sex with men presents with severe proctitis, tenesmus, and rectal bleeding. Rectal swab NAAT is positive for *Chlamydia trachomatis*. He was treated with Doxycycline 100 mg BID for 7 days with no improvement. His partner recently returned from Europe. Which of the following is the most appropriate management?", "options": ["Repeat Doxycycline 100 mg BID for 7 days", "Azithromycin 1 g single dose", "Ceftriaxone 500 mg IM single dose", "Extend Doxycycline 100 mg BID to complete a 21-day course", "Moxifloxacin 400 mg daily for 14 days"], "answer": "D", "answer_index": 3, "explanation": "Severe proctitis in MSM with a positive Chlamydia test should raise suspicion for Lymphogranuloma Venereum (LGV), caused by L1, L2, or L3 serovars. LGV requires a prolonged course of doxycycline (21 days) compared to non-LGV chlamydia (7 days). Standard treatment failure and severe symptoms (bleeding/tenesmus) strongly support a diagnosis of LGV.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. The vignette presents a classic scenario for Lymphogranuloma Venereum (LGV): an MSM patient with severe proctitis (bleeding, tenesmus), a positive rectal Chlamydia NAAT, and failure of the standard 7-day doxycycline regimen used for non-LGV strains. The epidemiological clue (partner from Europe) further increases the pre-test probability of LGV. CDC guidelines recommend that MSM with severe proctitis and rectal chlamydia be treated presumptively for LGV. The standard treatment for LGV is Doxycycline 100 mg BID for 21 days. Since the patient has already completed 7 days, the correct management is to extend the course to complete the full 21 days (Option D). Option A and B are insufficient for LGV. Option C treats Gonorrhea, which is not the primary concern given the specific Chlamydia finding and lack of Gonorrhea evidence (though empiric coverage is often combined, the specific question targets the Chlamydia management failure). The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. The vignette presents a classic scenario for Lymphogranuloma Venereum (LGV): an MSM patient with severe proctitis (bleeding, tenesmus), a positive rectal Chlamydia NAAT, and failure of the standard 7-day doxycycline regimen used for non-LGV strains. The epidemiological clue (partner from Europe) further increases the pre-test probability of LGV. CDC guidelines recommend that MSM with severe proctitis and rectal chlamydia be treated presumptively for LGV. The standard treatment for LGV is Doxycycline 100 mg BID for 21 days. Since the patient has already completed 7 days, the correct management is to extend the course to complete the full 21 days (Option D). Option A and B are insufficient for LGV. Option C treats Gonorrhea, which is not the primary concern given the specific Chlamydia finding and lack of Gonorrhea evidence (though empiric coverage is often combined, the specific question targets the Chlamydia management failure). The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-009", "question": "A 70-year-old man is evaluated for macrocytic anemia (MCV 105), thrombocytopenia, and recurrent inflammation of the ear and nose cartilage. He also has pulmonary infiltrates. Bone marrow biopsy demonstrates hypercellularity with vacuolization of myeloid and erythroid precursor cells. Genetic sequencing identifies a somatic mutation in *UBA1*. What is the diagnosis?", "options": ["Relapsing Polychondritis", "Myelodysplastic Syndrome (MDS)", "VEXAS Syndrome", "Sweet Syndrome", "Granulomatosis with Polyangiitis"], "answer": "C", "answer_index": 2, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in *UBA1*. It connects inflammatory features (polychondritis, vasculitis, infiltrates) with hematologic features (macrocytic anemia, vacuoles in marrow precursors). While it mimics relapsing polychondritis, the presence of marrow vacuoles and the *UBA1* mutation defines VEXAS.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem provides a textbook description of VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a recently defined hemato-inflammatory disorder. The key discriminating clues are the somatic *UBA1* mutation and the presence of vacuoles in myeloid and erythroid precursors in the bone marrow. These two features specifically distinguish VEXAS from its clinical mimics, such as Relapsing Polychondritis (Option A) and Myelodysplastic Syndrome (Option B), which are listed as distractors. The clinical phenotype (older man, macrocytic anemia, chondritis, pulmonary infiltrates) is perfectly aligned with the diagnosis. The item is logically sound because the genetic finding (*UBA1*) is the defining criterion for the syndrome, eliminating any ambiguity among the choices. The medical accuracy is high, reflecting current rheumatology and hematology standards. No changes are required.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem provides a textbook description of VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a recently defined hemato-inflammatory disorder. The key discriminating clues are the somatic *UBA1* mutation and the presence of vacuoles in myeloid and erythroid precursors in the bone marrow. These two features specifically distinguish VEXAS from its clinical mimics, such as Relapsing Polychondritis (Option A) and Myelodysplastic Syndrome (Option B), which are listed as distractors. The clinical phenotype (older man, macrocytic anemia, chondritis, pulmonary infiltrates) is perfectly aligned with the diagnosis. The item is logically sound because the genetic finding (*UBA1*) is the defining criterion for the syndrome, eliminating any ambiguity among the choices. The medical accuracy is high, reflecting current rheumatology and hematology standards. No changes are required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-010", "question": "A 35-year-old female undergoes a cone biopsy for CIN 3. Pathology reveals invasive squamous cell carcinoma with 2 mm depth of invasion and 5 mm horizontal spread. Lymphovascular space invasion (LVSI) is extensively present. Margins are negative. Imaging shows no lymphadenopathy. She desires future fertility. According to NCCN guidelines, what is the recommended management?", "options": ["Simple trachelectomy", "Radical trachelectomy with pelvic lymph node assessment", "Conization with negative margins is sufficient", "Simple hysterectomy", "Pelvic radiation therapy"], "answer": "B", "answer_index": 1, "explanation": "The patient has Stage IA1 cervical cancer (invasion <= 3mm). However, the presence of Lymphovascular Space Invasion (LVSI) significantly increases the risk of lymph node metastasis and recurrence. Therefore, simple excision (cone) or simple trachelectomy/hysterectomy is insufficient. The recommended management for fertility preservation in IA1 with LVSI is radical trachelectomy with pelvic lymph node assessment (sentinel node or dissection).", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient has Stage IA1 cervical cancer (depth < 3 mm) with lymphovascular space invasion (LVSI). While Stage IA1 without LVSI can be treated with conization alone, the presence of LVSI significantly increases the risk of lymph node metastasis. Therefore, NCCN guidelines recommend pelvic lymph node assessment (PLND or sentinel lymph node mapping) for Stage IA1 with LVSI. For fertility preservation, the options are either Conization + PLND or Radical Trachelectomy + PLND. Option C is incorrect because it describes conization alone as 'sufficient,' ignoring the need for lymph node assessment mandated by the LVSI. Option D removes the uterus, failing the fertility requirement. Option A (Simple trachelectomy) is not the standard NCCN recommendation for LVSI-positive disease (which typically requires parametrial evaluation or at least nodal assessment not implied by 'simple' alone in older algorithms, though 'Cone + LND' is the less morbid preferred option). Among the choices provided, Option B is the only one that includes the necessary lymph node assessment and preserves fertility, aligning with NCCN guidelines (which list Radical Trachelectomy + PLND as a valid, albeit more aggressive, option).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient has Stage IA1 cervical cancer (depth < 3 mm) with lymphovascular space invasion (LVSI). While Stage IA1 without LVSI can be treated with conization alone, the presence of LVSI significantly increases the risk of lymph node metastasis. Therefore, NCCN guidelines recommend pelvic lymph node assessment (PLND or sentinel lymph node mapping) for Stage IA1 with LVSI. For fertility preservation, the options are either Conization + PLND or Radical Trachelectomy + PLND. Option C is incorrect because it describes conization alone as 'sufficient,' ignoring the need for lymph node assessment mandated by the LVSI. Option D removes the uterus, failing the fertility requirement. Option A (Simple trachelectomy) is not the standard NCCN recommendation for LVSI-positive disease (which typically requires parametrial evaluation or at least nodal assessment not implied by 'simple' alone in older algorithms, though 'Cone + LND' is the less morbid preferred option). Among the choices provided, Option B is the only one that includes the necessary lymph node assessment and preserves fertility, aligning with NCCN guidelines (which list Radical Trachelectomy + PLND as a valid, albeit more aggressive, option).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]